Quantifying CDK inhibitor selectivity in live cells
Cyclin-dependent kinase (CDK) inhibitors are widely used both in the clinic and for basic research aimed at dissecting the specific cellular functions of specific CDKs. Here, the authors report the development of a panel of fluorescent reporter probes and provide a comprehensive profile of the inhib...
Saved in:
Main Authors: | Carrow I. Wells, James D. Vasta, Cesear R. Corona, Jennifer Wilkinson, Chad A. Zimprich, Morgan R. Ingold, Julie E. Pickett, David H. Drewry, Kathryn M. Pugh, Marie K. Schwinn, Byounghoon (Brian) Hwang, Hicham Zegzouti, Kilian V. M. Huber, Mei Cong, Poncho L. Meisenheimer, Timothy M. Willson, Matthew B. Robers |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/5ab2cf72cb7f4b5ea0a65e02f4e02daf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor
by: Tigist Y. Tamir, et al.
Published: (2020) -
Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
by: Lindsey R. Pack, et al.
Published: (2021) -
Three decades of Cdk5
by: Ping-Chieh Pao, et al.
Published: (2021) -
CDK1 phosphorylates WRN at collapsed replication forks
by: Valentina Palermo, et al.
Published: (2016) -
The Role of CDK4 in the Pathogenesis of Pancreatic Cancer
by: Emily Jiggens, et al.
Published: (2021)